136 related articles for article (PubMed ID: 31550720)
1. Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease.
Lai S; Mangiulli M; Perrotta AM; Di Lazzaro Giraldi G; Testorio M; Rosato E; Cianci R; Gigante A
Kidney Blood Press Res; 2019; 44(5):1142-1148. PubMed ID: 31550720
[TBL] [Abstract][Full Text] [Related]
2. Screening of QTc interval and global autonomic activity in autosomal dominant polycystic kidney disease and atherosclerotic renal artery stenosis hypertensive patients.
Lai S; Perrotta AM; Bagordo D; Mazzaferro S; Menè P; Gigante A; Tinti F; Galani A; Cianci R
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6333-6338. PubMed ID: 34730214
[TBL] [Abstract][Full Text] [Related]
3. Parasympathetic activity and total fibrotic kidney in autosomal-dominant polycystic kidney disease patients: a pilot study.
Lai S; Perrotta AM; Panebianco V; Mazzaferro S; Menè P; Pellicano C; Tinti F; Muscaritoli M; Cianci R; Gigante A
Int Urol Nephrol; 2023 Dec; 55(12):3153-3158. PubMed ID: 37043156
[TBL] [Abstract][Full Text] [Related]
4. Uroflowmetry alterations in patients with autosomal dominant polycystic kidney disease.
Lai S; Mittherhofer AP; Cianci R; Riviello L; Vocaturi M; Mastroluca D; Ciccariello M; Von Heland M; Ricciuti GP; Salciccia S; Mazzaferro S
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2734-2743. PubMed ID: 31002123
[TBL] [Abstract][Full Text] [Related]
5. Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: influence of blood pressure and humoral and neurohormonal factors.
Martinez-Vea A; Valero FA; Bardaji A; Gutierrez C; Broch M; Garcia C; Richart C; Oliver JA
Am J Nephrol; 2000; 20(3):193-200. PubMed ID: 10878400
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular Risk and Quality of Life in Autosomal Dominant Polycystic Kidney Disease Patients on Therapy With Tolvaptan: A Pilot Study.
Lai S; Mangiulli M; Perrotta AM; Gigante A; Napoleoni L; Cipolloni E; Mitterhofer AP; Gasperini ML; Muscaritoli M; Cianci R; Giovannetti A; Falco F; Mastroluca D; Mazzaferro S
Curr Vasc Pharmacol; 2021; 19(5):556-564. PubMed ID: 32957887
[TBL] [Abstract][Full Text] [Related]
7. Association of OSR-1 With Vascular Dysfunction and Hypertension in Polycystic Kidney Disease.
Kocyigit I; Taheri S; Eroglu E; Zararsiz G; Sener EF; Uzun I; Imamoglu H; Mehmetbeyoglu E; Unal A; Korkmaz K; Sipahioglu MH; Oymak O; Tokgoz B
Ther Apher Dial; 2020 Feb; 24(1):64-71. PubMed ID: 31020807
[TBL] [Abstract][Full Text] [Related]
8. α-lipoic acid in patients with autosomal dominant polycystic kidney disease.
Lai S; Petramala L; Muscaritoli M; Cianci R; Mazzaferro S; Mitterhofer AP; Pasquali M; D'Ambrosio V; Carta M; Ansuini M; Ramaccini C; Galani A; Amabile MI; Molfino A; Letizia C
Nutrition; 2020 Mar; 71():110594. PubMed ID: 31790890
[TBL] [Abstract][Full Text] [Related]
9. Epicardial Fat Thickness in Patients with Autosomal Dominant Polycystic Kidney Disease.
Concistrè A; Petramala L; Scoccia G; Sciomer S; Bisogni V; Saracino V; Iannucci G; Lai S; Mastroluca D; Iacobellis G; Letizia C
Cardiorenal Med; 2018; 8(3):199-207. PubMed ID: 29723863
[TBL] [Abstract][Full Text] [Related]
10. Impairment of heart rate recovery index in autosomal-dominant polycystic kidney disease patients without hypertension.
Orscelik O; Kocyigit I; Baran O; Kaya C; Dogdu O; Zengin H; Karadavut S; Gedikli O; Kut E; Duran M; Calapkorur B; Tokgoz B; Kaya MG
Blood Press; 2012 Oct; 21(5):300-5. PubMed ID: 22545873
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.
Gorriz JL; Arroyo D; D'Marco L; Torra R; Tomás P; Puchades MJ; Panizo N; Pantoja J; Montomoli M; Llisterri JL; Pallares-Carratalá V; Valdivielso JM
BMC Nephrol; 2021 Mar; 22(1):110. PubMed ID: 33765945
[TBL] [Abstract][Full Text] [Related]
12. Standardized tests of heart rate variability for autonomic function tests in healthy Koreans.
Park SB; Lee BC; Jeong KS
Int J Neurosci; 2007 Dec; 117(12):1707-17. PubMed ID: 17987472
[TBL] [Abstract][Full Text] [Related]
13. Circadian heart rate variability in patients with primary arterial hypertension.
Kolasińska-Kloch W; Furgała A; Banach T; Laskiewicz J; Thor PJ
Przegl Lek; 2002; 59(9):752-5. PubMed ID: 12632903
[TBL] [Abstract][Full Text] [Related]
14. Arterial dysfunction in early autosomal dominant polycystic kidney disease independent of fibroblast growth factor 23.
Yildiz A; Gul CB; Ersoy A; Asiltas B; Ermurat S; Dogan S; Karaagac K; Sag S; Oruc A; Aktas N; Ocakoglu G; Dogan I; Gullulu S; Gullulu M
Iran J Kidney Dis; 2014 Nov; 8(6):443-9. PubMed ID: 25362218
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease.
Kocaman O; Oflaz H; Yekeler E; Dursun M; Erdogan D; Demirel S; Alisir S; Turgut F; Mercanoglu F; Ecder T
Am J Kidney Dis; 2004 May; 43(5):854-60. PubMed ID: 15112176
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers as first-line treatment in autosomal dominant polycystic kidney disease.
Clark LA; Whitmire S; Patton S; Clark C; Blanchette CM; Howden R
J Med Econ; 2017 Jul; 20(7):715-722. PubMed ID: 28332417
[TBL] [Abstract][Full Text] [Related]
17. A systematic review and meta-analysis of heart rate variability in epilepsy and antiepileptic drugs.
Lotufo PA; Valiengo L; Benseñor IM; Brunoni AR
Epilepsia; 2012 Feb; 53(2):272-82. PubMed ID: 22221253
[TBL] [Abstract][Full Text] [Related]
18. Autosomal dominant polycystic kidney disease and hypertension are associated with left ventricular mass in a gender-dependent manner.
Pietrzak-Nowacka M; Safranow K; Czechowska M; Dutkiewicz G; Kornacewicz-Jach Z; Ciechanowski K
Kidney Blood Press Res; 2012; 36(1):301-9. PubMed ID: 23235185
[TBL] [Abstract][Full Text] [Related]
19. Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.
Chapman AB; Guay-Woodford LM; Grantham JJ; Torres VE; Bae KT; Baumgarten DA; Kenney PJ; King BF; Glockner JF; Wetzel LH; Brummer ME; O'Neill WC; Robbin ML; Bennett WM; Klahr S; Hirschman GH; Kimmel PL; Thompson PA; Miller JP;
Kidney Int; 2003 Sep; 64(3):1035-45. PubMed ID: 12911554
[TBL] [Abstract][Full Text] [Related]
20. Tissue Doppler imaging in the evaluation of left ventricular function in young adults with autosomal dominant polycystic kidney disease.
Almeida EA; Oliveira EI; Lopes JA; Almeida AG; Prata MM
Am J Kidney Dis; 2006 Apr; 47(4):587-92. PubMed ID: 16564936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
